Orange County Business Journal

Edwards Comeback Continues on OK for Sapien XT

Edwards Lifesciences Corp.’s next generation of less-invasive heart valves is making its domestic debut, providing a boost that has extended a monthslong rally for shares of the Irvine-based heart ...
TCTMD

Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes in 94 Center Post-Approval Study

Company Receives CE Mark Approval for 29 mm Transfemoral System First Human Experience With Next-Generation Valve Platforms to Be Presented PARIS-- Edwards Lifesciences Corporation, the global leader ...
TCTMD

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

IRVINE, CA. -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve ...
Orange County Business Journal

Edwards Ready to Roll on Sapien Sales

Irvine-based Edwards Lifesciences Corp. is wasting no time getting its recently approved heart valve on the market here. Edwards Sapien is a less-invasive device that’s widely considered one of the ...
Business Wire

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...
Business Wire

Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data

LONDON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented ...
Nasdaq

Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive

A leading player in the field of structural heart disease and critical care monitoring, Edwards Lifesciences CorporationEW recently unveiled positive one-year data on its SAPIEN 3 transcatheter heart ...
FierceBiotech

Edwards' next-gen Sapien heart valve gains Japanese reimbursement

Japan granted an insurance reimbursement for the Sapien XT valve.--Courtesy of Edwards Lifesciences Edwards Lifesciences' ($EW) Sapien heart-valve revenue engine gets ...
FierceBiotech

Edwards up 13% on Sapien TAVR data in intermediate-risk heart patients

CHICAGO--Edwards Lifesciences ($EW) is on track to be the first to meet the demand for TAVR implantation in an additional patient cohort following the success of the ...
MD&M East

Edwards Eyes Delay for its Sapien 3 Ultra TAVR

Edwards Lifesciences said it is delaying the launch of the Sapien 3 Ultra transcatheter aortic valve replacement (TAVR) System in Europe until later this year. The Irvine, CA-based company said it ...
Seeking Alpha

FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...